logo

INM

InMed
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

INM Profile

Inmed Pharmaceuticals Inc.

A leader in the research, development and manufacturing of rare cannabinoids

Pharmaceutical
05/19/1981
11/12/2020
NASDAQ Stock Exchange
13
06-30
Common stock
1445, 885 West Georgia St., Vancouver, B.C., Canada V6C 3E8
--
InMed Pharmaceuticals Inc., was incorporated in British Columbia on May 19, 1981 under the British Columbia Business Companies Act. The company is a clinical-stage pharmaceutical company that develops prescription drugs for diseases with unmet medical needs and develops patented manufacturing technologies. The company is developing an integrated manufacturing method based on biosynthesis, called IntegraSynTM, for the synthesis of pharmaceutical-grade cannabinoids as well as a variety of product candidates. The company is committed to providing new therapeutic alternatives to patients who may benefit from cannabinoid-based drugs.